BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Brain Tumour Foundation of Canada - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Brain Tumour Foundation of Canada
X-ORIGINAL-URL:https://www.braintumour.ca
X-WR-CALDESC:Events for Brain Tumour Foundation of Canada
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20251015T120000
DTEND;TZID=America/Toronto:20251015T130000
DTSTAMP:20261017T011308
CREATED:20251002T035931Z
LAST-MODIFIED:20251002T035931Z
UID:10000348-1760529600-1760533200@www.braintumour.ca
SUMMARY:Creating a user centric neuro-oncology program through the empowerment of patients and providers
DESCRIPTION:In this presentation we will discuss how academic and entrepreneurial approaches were combined to create a user-centric\, rapidly adaptive brain tumour program.  \nIn this webinar\, you will learn to:  \n\nReview barriers to care for Canadians diagnosed with brain tumours. \nIntroduce the design thinking paradigm for product development. \nShare practical interventions that empower patients and reduce administrative burden for healthcare workers.\n\nSpeaker bio:\nDr. Teresa Purzner earned her MD in 2009 and completed four years of neurosurgical residency in Toronto before pursuing a PhD in developmental neurobiology at Stanford University. There\, she combined mass spectrometry with developmental biology to identify novel therapeutic targets for pediatric brain tumours\, leading to the discovery of a new drug target in medulloblastoma. In collaboration with Stanford SPARK and the Pediatric Brain Tumor Consortium\, she helped translate this discovery into a first-in-child clinical trial of a CK2 inhibitor. Her work has been recognized with numerous awards\, including the Stanford Interdisciplinary Graduate and BioX Fellowship\, the Annual Award of the American Academy of Neurological Surgery\, the Weston Havens Foundation Award\, the AANS Louise Eisenhardt Award\, and the Neurosurgery Research and Education Fellowship. In 2021\, she was named one of Canada’s Top 40 Under 40. Dr. Purzner is also the founder of Cerebelly\, a science-based baby food company focused on early brain development\, now available in over 15\,000 stores across North America. Dr. Purzner now runs a neurosurgical practice and translational research lab at Queen’s University with her husband\, Dr. James Purzner. Together\, they focus on advancing care and scientific understanding for patients with brain tumours through integrated clinical and research innovation.  \nRegister
URL:https://www.braintumour.ca/event/creating-a-user-centric-neuro-oncology-program-through-the-empowerment-of-patients-and-providers/
CATEGORIES:Webinar Series
ATTACH;FMTTYPE=image/png:https://www.braintumour.ca/wp-content/uploads/2025/10/Teresa-Webinar-Headshot-Webinar-Page.png
LOCATION:
END:VEVENT
END:VCALENDAR